Everett Harris & Co. CA raised its position in Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) by 327.7% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 17,116 shares of the medical instruments supplier's stock after purchasing an additional 13,114 shares during the quarter. Everett Harris & Co. CA owned about 0.52% of Utah Medical Products worth $959,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors also recently made changes to their positions in the company. Tower Research Capital LLC TRC increased its stake in shares of Utah Medical Products by 172.6% in the fourth quarter. Tower Research Capital LLC TRC now owns 518 shares of the medical instruments supplier's stock valued at $32,000 after purchasing an additional 328 shares during the period. Wells Fargo & Company MN increased its stake in shares of Utah Medical Products by 24.9% during the fourth quarter. Wells Fargo & Company MN now owns 1,927 shares of the medical instruments supplier's stock valued at $118,000 after acquiring an additional 384 shares during the period. Bessemer Group Inc. acquired a new position in shares of Utah Medical Products during the fourth quarter valued at approximately $31,000. Golden State Wealth Management LLC increased its stake in shares of Utah Medical Products by 100.0% during the first quarter. Golden State Wealth Management LLC now owns 1,000 shares of the medical instruments supplier's stock valued at $56,000 after acquiring an additional 500 shares during the period. Finally, PNC Financial Services Group Inc. increased its stake in shares of Utah Medical Products by 156.9% during the first quarter. PNC Financial Services Group Inc. now owns 894 shares of the medical instruments supplier's stock valued at $50,000 after acquiring an additional 546 shares during the period. Institutional investors and hedge funds own 69.60% of the company's stock.
Utah Medical Products Price Performance
Shares of NASDAQ UTMD traded up $1.39 during mid-day trading on Tuesday, reaching $57.64. 2,541 shares of the company traded hands, compared to its average volume of 18,099. Utah Medical Products, Inc. has a fifty-two week low of $51.26 and a fifty-two week high of $69.30. The firm has a market cap of $187.33 million, a PE ratio of 15.41 and a beta of 0.31. The stock has a fifty day simple moving average of $56.38 and a 200-day simple moving average of $56.45.
Utah Medical Products (NASDAQ:UTMD - Get Free Report) last posted its quarterly earnings data on Thursday, July 24th. The medical instruments supplier reported $0.94 EPS for the quarter. Utah Medical Products had a net margin of 32.34% and a return on equity of 10.50%. The business had revenue of $9.95 million for the quarter.
Utah Medical Products Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 2nd. Investors of record on Wednesday, September 17th will be paid a dividend of $0.305 per share. This represents a $1.22 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date is Wednesday, September 17th. Utah Medical Products's dividend payout ratio (DPR) is currently 32.62%.
Utah Medical Products Profile
(
Free Report)
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
Further Reading

Before you consider Utah Medical Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Utah Medical Products wasn't on the list.
While Utah Medical Products currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.